Clinical Trial Update: Evaluating the Efficacy and Safety of HSK21542 Injection in Chemotherapy-induced Nausea and Vomiting [Phase 2]

View source ↗

Summary

The document describes a Phase 2 clinical trial evaluating the efficacy and safety of HSK21542 Injection for chemotherapy-induced nausea and vomiting, with stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• HSK21542

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: Nausea and Vomiting, Chemotherapy-Induced | Phase 2 | Status: NOT_YET_RECRUITING